TI - Shared and unique determinants of the <p1  pair=1 >  <prot>  <prot>  erythropoietin </prot>  ( <prot>  EPO </prot>  ) receptor </prot>  </p1>  are important for binding <p2  pair=1 >  <prot>  EPO </prot>  </p2>  and <prot>  <prot>  EPO </prot>  mimetic peptide </prot>  .
PG - 14163 - 9 AB - We have shown previously that Phe93 in the extracellular domain of the <p1  pair=3 >  <prot>  <p1  pair=14 >  <prot>  erythropoietin </prot>  </p1>  ( <p1  pair=11 >  <prot>  EPO </prot>  </p1>  ) receptor </prot>  </p1>  ( <p1  pair=4 >  <p2  pair=14 >  <p2  pair=11 >  <prot>  EPOR </prot>  </p2>  </p2>  </p1>  ) is crucial for binding <p2  pair=3 >  <p2  pair=4 >  <prot>  EPO </prot>  </p2>  </p2>  Substitution of Phe93 with alanine resulted in a dramatic decrease in <p1  pair=10 >  <p1  pair=5 >  <p1  pair=6 >  <prot>  EPO </prot>  </p1>  </p1>  </p1>  binding to the Escherichia coli - expressed extracellular domain of the <p2  pair=10 >  <prot>  EPOR </prot>  </p2>  ( <p2  pair=5 >  <prot>  <prot>  EPO </prot>  - binding protein </prot>  </p2>  or <p2  pair=6 >  <prot>  EBP </prot>  </p2>  ) and no detectable binding to full - length mutant receptor expressed in COS cells .
Remarkably , Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the <p1  pair=15 >  <p1  pair=7 >  <prot>  EBP </prot>  </p1>  </p1>  bound to an <prot>  <prot>  EPO </prot>  - mimetic peptide </prot>  ( <p2  pair=7 >  <prot>  EMP1 </prot>  </p2>  ) , suggesting that Phe93 is also important for <p2  pair=15 >  <prot>  EMP1 </prot>  </p2>  binding .
We used alanine substitution of <p1  pair=2 >  <p1  pair=8 >  <p1  pair=9 >  <prot>  EBP </prot>  </p1>  </p1>  </p1>  residues that contact <p2  pair=2 >  <prot>  EMP1 </prot>  </p2>  in the crystal structure to investigate the function of these residues in both <p2  pair=8 >  <prot>  EMP1 </prot>  </p2>  and <p2  pair=9 >  <prot>  EPO </prot>  </p2>  binding .
The three largest hydrophobic contacts at Phe93 , Met150 , and Phe205 and a hydrogen bonding interaction at Thr151 were examined .
Our results indicate that Phe93 and Phe205 are important for both <prot>  EPO </prot>  and <prot>  EMP1 </prot>  binding , Met150 is not important for <prot>  EPO </prot>  binding but is critical for <prot>  EMP1 </prot>  binding , and Thr151 is not important for binding either ligand .
Thus , Phe93 and Phe205 are important binding determinants for both <p1  pair=12 >  <prot>  EPO </prot>  </p1>  and <p1  pair=13 >  <prot>  EMP1 </prot>  </p1>  , even though these ligands share no sequence or structural homology , suggesting that these residues may represent a minimum epitope on the <p2  pair=12 >  <p2  pair=13 >  <prot>  EPOR </prot>  </p2>  </p2>  for productive ligand binding .
AD - R .
W .
Johnson Pharmaceutical Research Institute , Raritan , New Jersey
